(Q51677614)

9 April 2018

title

Exhaled nitric oxide in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (English)

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

allergic bronchopulmonary aspergillosis

23 December 2023

main subject

0 references

0 references

1

A. Y H. Lim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693794

23 December 2023

2

D. C. Chambers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693794

23 December 2023

author name string

Lim AY

1

1 reference

9 April 2018

J. G. Ayres

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693794

23 December 2023

D. E. Stableforth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693794

23 December 2023

D. Honeybourne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693794

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12693794

23 December 2023

publication date

1 April 2003

1 reference

9 April 2018

full work available at URL

https://doi.org/10.1053/rmed.2002.1430

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693794

https://api.elsevier.com/content/article/PII:S0954611102914307?httpAccept=text/xml

23 December 2023

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

https://api.elsevier.com/content/article/PII:S0954611102914307?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

23 December 2023

1 reference

9 April 2018

volume

97

1 reference

9 April 2018

issue

4

1 reference

9 April 2018

page(s)

331-336

1 reference

9 April 2018

Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans

cites work

1

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

The biology of nitrogen oxides in the airways

23 December 2023

3

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Expression of inducible nitric oxide in human lung epithelial cells.

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma

23 December 2023

5

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Exhaled Nitric Oxide, Sensitization, and Exposure to Allergens in Patients with Asthma Who Are Not Taking Inhaled Steroids

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis

23 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype

23 December 2023

9

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Broncho-pulmonary aspergillosis; a review and a report of eight new cases

23 December 2023

10

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis

23 December 2023

13

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis

23 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Late sequelae of allergic bronchopulmonary aspergillosis

23 December 2023

19

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Aspergillosis and atopy in cystic fibrosis

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis

23 December 2023

22

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis

23 December 2023

24

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis

23 December 2023

26

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

23 December 2023

28

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma

23 December 2023

29

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Effect of nebulised L- and D-arginine on exhaled nitric oxide in steroid naive asthma

23 December 2023

30

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma.

23 December 2023

32

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Inhibition of the alveolar macrophage oxidative burst by a diffusible component from the surface of the spores of the fungus Aspergillus fumigatus

23 December 2023

33

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression

23 December 2023

35

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis

23 December 2023

36

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

Precipitating antibodies to aspergillus fumigatus in cystic fibrosis

23 December 2023

38

1 reference

https://api.crossref.org/works/10.1053/RMED.2002.1430

23 December 2023

Identifiers

1 reference

9 April 2018

release_llmkcwwj5fa5zi3ovnn64mvloi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/llmkcwwj5fa5zi3ovnn64mvloi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

9 April 2018